Updated July 2026 · 8 min read
Part of the ICU Pharmacology Hub — browse every related guide in one place.
Crystalloid is the default resuscitation fluid in nearly every ICU. Albumin is the expensive colloid that gets pulled out for specific patients. Knowing where the colloid earns its cost — and where a landmark trial says to avoid it — separates protocol-following from actual understanding at the bedside.
Crystalloids are salt-water solutions; their small molecules distribute across the whole extracellular space, so only about a quarter to a third of what you infuse stays in the bloodstream — the rest moves into the tissues. Colloids like albumin carry large protein molecules that exert oncotic pressure and, in theory, hold fluid inside the vessels longer, so a smaller volume produces a similar rise in intravascular volume. That theoretical efficiency is real but modest, and in critically ill patients with leaky capillaries even albumin escapes the circulation more than the textbook suggests — which is a big reason the outcome advantage never materialized in trials.
The reason albumin isn't the default despite its physiology is that large studies put it to the test. The SAFE trial compared albumin to saline for ICU resuscitation and found no overall mortality difference — the two were essentially equivalent, which, given albumin's far higher cost, made crystalloid the sensible default. A pre-specified look inside that data revealed a warning: patients with traumatic brain injury did worse with albumin. Later, the ALBIOS trial in severe sepsis found that adding albumin to crystalloid didn't improve overall survival, though it remained a reasonable option in specific patients. The takeaway nurses can carry: albumin is not harmful across the board, but it isn't a survival upgrade over crystalloid in general resuscitation — and it's genuinely dangerous in TBI.
The strongest indications cluster around liver disease. After a large-volume paracentesis, albumin reduces post-paracentesis circulatory dysfunction. In spontaneous bacterial peritonitis (SBP), albumin plus antibiotics reduces renal failure and death. In hepatorenal syndrome, albumin is part of the treatment alongside vasoconstrictors. Outside hepatology, albumin is sometimes chosen in sepsis when a patient has needed large crystalloid volumes and remains hypotensive (as a way to limit further crystalloid load), and occasionally to support oncotic pressure in profound hypoalbuminemia — but these are selective, not routine, uses.
Among crystalloids, there's a second decision the nurse should recognize: balanced solutions (lactated Ringer's, Plasma-Lyte) versus 0.9% normal saline. Large volumes of normal saline can cause a hyperchloremic metabolic acidosis, and trials suggest balanced fluids may be gentler on the kidneys in many ICU patients. Saline is still preferred in specific situations (for example, hyponatremia or certain neuro cases). So "crystalloid" isn't one answer — which crystalloid is its own bedside consideration.
| Scenario | Reasonable fluid choice |
|---|---|
| General shock/sepsis resuscitation | Crystalloid first-line (often a balanced solution) |
| Traumatic brain injury | Isotonic crystalloid — avoid albumin |
| Large-volume paracentesis | Albumin to prevent circulatory dysfunction |
| Spontaneous bacterial peritonitis | Albumin + antibiotics |
| Hepatorenal syndrome | Albumin + vasoconstrictor |
| Refractory sepsis after large crystalloid load | Albumin as a selective add-on |
Related: Albumin guide for ICU nurses · ICU sepsis protocol · Massive transfusion protocol · Vasopressor guide
Educational content for licensed clinicians. Always follow your facility's pharmacy dosing protocol and provider orders. Not medical advice.
Get The ICU Notebook Newsletter
Clinical tools and career insights for ICU nurses. One email per week, no fluff.
Yes, send it freeNo spam. Unsubscribe any time.